Join for free and get access to the buyside
Get insights from the world's most influential hedge fund investors direct to your inbox
- © 2025 Buyside Digest
- Privacy Policy
- Disclaimer
- Sitemap
- Terms of Service
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2025 Q2 | Jul 2, 2025 | AVI Global Trust | - | - | 4527 JP, 7912 JP, AKRBP NO, APO, CDI FP, DIE BB, ENT LN, GXI GR, NWSA, RKT LN | activism, catalysts, Closed-End Funds, Discounts, net asset value | The letter focuses on unlocking value in closed-end funds trading at persistent discounts to net asset value. Management highlights activism, corporate actions, and market catalysts as tools to narrow discounts and enhance shareholder returns. The outlook remains constructive given wide discounts and improving sentiment. | View | |
| 2025 Q3 | Nov 13, 2025 | AVI Global Trust | - | 12.4% | 028260 KS, NWSA | Balance Sheets, Buybacks, Corporate Actions, Discounts, value | The letter emphasizes value investing in asset-rich, cash-generative companies trading at discounts to intrinsic value due to complexity, governance issues, or cyclical pessimism. A focus on balance sheet strength and corporate actions such as buybacks and restructurings underpins return generation. Value investing is positioned to benefit from discount narrowing as fundamentals assert themselves. | NWSA 028260 KS |
View |
| 2025 Q4 | Jan 13, 2026 | AVI Global Trust | 0.0% | -0.9% | 000660.KS, 004800.KS, 005930.KS, 028260.KS, 207940.KS, 4527.T, 6727.T, 9531.T, AVGO, CHRY.L, FRAS.L, J36.SI, NVDA, NWSA, VIV.PA | Biotechnology, Discounts, Holding Companies, Korea, NAV, semiconductors, technology, value | Samsung Electronics has made material progress in improving HBM competitiveness, with latest HBM4 chips achieving top performance scores in Nvidia and Broadcom testing. The company is positioned to capture 30%+ global HBM market share in 2026 versus mid-teens in 2025. Global supply shortage for both HBM and traditional memory chips is creating strong pricing power. Samsung Biologics manufactures antibodies on behalf of global pharmaceutical companies, generating 90% of revenues from large-scale antibody production. The company generates EBIT margins of 50% versus peers at 20-25% and operates one of the world's largest biomanufacturing facilities. Biologics is positioned to compound earnings at mid-teens rates through to 2032. Starling Bank's banking-as-a-service platform Engine won a deal with Scotiabank's digital bank, marking Engine's first North American client. The deal is viewed as transformational in the context of the business's existing revenues. Management painted an optimistic picture for Engine's sales pipeline at a recent fintech conference. | 028260 KS CHRY LN |
View |
| 2022 Q3 | Aug 11, 2022 | Steel City Capital | -7.9% | -18.2% | ATEX, CVNA, LILA, NWSA, SATS, YELP | - | View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| Jan 15, 2026 | Fund Letters | Joe Bauernfreund | News Corporation | Communication Services | Media | Bull | NASDAQ | buybacks, discount, Governance, media, Sumofparts | View Pitch |
| Oct 23, 2025 | Value Investors Club | Norris | News Corp | Communication Services | Publishing | Bull | NASDAQ | Audiobooks, buybacks, Data licensing, Digital Subscriptions, Real Estate Portals, Spin-offs | View Pitch |
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||